Buscar
01/05/2025
CBCT dose optimisation in prostate IGRT
Perea, AD, Sala, NJ, Martínez, AR, Pagès, MB, García, JR, Marcos, CA, Molinero, VR, Fernandez, JPA, Franco, PG, Aguilar, NT, Bargalló, HV, Rey, EMA, Martin, AR, Arnal, CF, Gomez, MVM, Parreño, IA, Moreno, SG, González, JMR, Rull, FJC, Martin, DM, Deulofeu, AM, Martínez, SB, Errasti, AM, Pardo, GS, de Fez, PC. CBCT dose optimisation in prostate IGRT. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2025
Dosimetric Impact of Different CT Image Sets on Lung SBRT Planning
Bargalló, HV, Aguilar, NT, Sala, NJ, Fernández, JPA, Marco, CA, Franco, PG, Rey, EMA, Pagès, MB, Martínez, AR, Perea, AD, Molinero, VR, García, JR, Bernardó, NF, de Fez, PC. Dosimetric Impact of Different CT Image Sets on Lung SBRT Planning. RADIOTHERAPY AND ONCOLOGY. 2025; 206DOI:. PMID:. IF:5.300(Q1/2D).
17/04/2025
Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?
Gomis-Sellés, E, Maldonado, A, Gaztañaga, M, Vera, V, Ajulia, O, Sancho, G, Siva, S, Lopez-Campos, F, Couñago, F. Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?. Cancers. 2025; 17(8)DOI:10.3390/cancers17081350. PMID:40282526. IF:4.400(Q2/3D).
11/03/2025
Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients
Otero-Pla, E, Raspall, MJF, Franco, PG, Martínez, JF, Saladich, IG, Sala, NJ, Gisbert, ML, Cordero, JR, Verdum, JI, Sancho-Pardo, G. Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients. Frontiers in Oncology. 2025; 15DOI:10.3389/fonc.2025.1552908. PMID:40134591. IF:3.300(Q2/4D).
01/01/2025
Economic Evaluation of Traditional Treatments for Localized Prostate Cancer: A 10-Year Cohort Study
Zamora, V, Bosch, G, Becerra, V, Garin, O, Avila, M, Gutiérrez, C, Suárez, JF, Goñi, A, Macías, V, Mariño, A, Hervás, A, Herruzo, I, Cabrera, P, de León, JP, Sancho, G, Pont, A, Rubio-Valera, M, Alonso, J, Cots, F, Guedea, F, Castells, M, Ferrer, M. Economic Evaluation of Traditional Treatments for Localized Prostate Cancer: A 10-Year Cohort Study. EUROPEAN JOURNAL OF CANCER CARE. 2025; 2025(1)DOI:10.1155/ecc/3563061. PMID:. IF:1.900(Q2/4D).
11/11/2024
MAGNETIC RESONANCE SPECTROSCOPY IN THE POST-TREATMENT METABOLIC CHARACTERIZATION OF BRAIN TUMORS OF GLIAL ORIGIN OF CENTRAL NERVOUS SYSTEM
Acosta, PM, Malaver, G, Padin, TG, Gamboa, O, Singh, C, Rodriguez, C, Balart, J, Zubieta, C, Bouleftour, W, Magné, N, Penagos, P, Fino, D. MAGNETIC RESONANCE SPECTROSCOPY IN THE POST-TREATMENT METABOLIC CHARACTERIZATION OF BRAIN TUMORS OF GLIAL ORIGIN OF CENTRAL NERVOUS SYSTEM. NEURO-ONCOLOGY. 2024; 26DOI:10.1093/neuonc/noae165.0820. PMID:. IF:13.400(Q1/1D).
01/06/2024
Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature
Mármol, MCC, Aguado, M, Cajal, TRY, Gallardo, A, Catasus, L, Gonzalez, A, Mendez, JE, Lasa, A, Arumi, M, Rubio, OG, Serra, JB, Hernandez, FM, von Deimling, A, Kommoss, FKF, Espinosa, I. Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature. Pathologica. 2024; 116(3)DOI:10.32074/1591-951X-970. PMID:38979591. IF:(Q/D).
01/06/2024
PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform
Basterretxea, L, Hernandez, A, Gurruchaga, I, Mediavilla, BG, Espinos, EL, Esteban, B, Cacho, D, Congregado, B, Belenchon, IR, Sancho, G, Lainez, N, Buchser, D, Sanguedolce, F, Lashey, M, Duran, I. PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).